Larvol Delta - MWX203IIDLP-Phase-2-Clinical-Study-of-MWX203-Injection-Alone-or-in-Combination-With-Inclisiran-Sodium-Injection-in-Patients-With-Mixed-Dyslipidemia

Leqvio (inclisiran) - Novartis

MWX-203 - Minwei Biotech

http://clinicaltrials.gov/ct2/show/NCT07803822

Sep 5, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next